Stockscreener 앱 받기
33.56
4.06%
-1.42
시간 외 거래:
33.16
-0.40
-1.19%
전일 마감가:
$34.98
열려 있는:
$35.75
하루 거래량:
6.50M
Relative Volume:
1.04
시가총액:
$3.77B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-36.09
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
+12.92%
1개월 성능:
+29.73%
6개월 성능:
+55.95%
1년 성능:
-46.26%
1일 변동 폭
$33.17
$35.92
1주일 범위
$30.50
$35.92
52주 변동 폭
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
33.56 | 3.93B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.1%What's Next? - MarketBeat
Will a bounce in Viking Therapeutics Inc. offer an exitJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Sector ETF performance correlation with Viking Therapeutics Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Key metrics from Viking Therapeutics Inc.’s quarterly dataGold Moves & Accurate Intraday Trade Tips - newser.com
Viking Therapeutics Inc. stock volume spike explainedLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Wealth Enhancement Advisory Services LLC Purchases New Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Analyzing Viking Therapeutics Inc. with risk reward ratio charts2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1%Should You Buy? - MarketBeat
Why Shares in Viking Therapeutics Surged This Week - sharewise.com
Viking Therapeutics (VKTX) Shares Surge Amid Acquisition Activit - GuruFocus
Viking Therapeutics (VKTX) Rises Amid Akero Therapeutics Acquisi - GuruFocus
Viking, Genfit, Sagimet jump on Novo- Akero deal (AKRO:NASDAQ) - Seeking Alpha
Volume spikes in Viking Therapeutics Inc. stock – what they meanJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Visualizing Viking Therapeutics Inc. stock with heatmapsVolume Spike & Weekly High Momentum Picks - newser.com
Will Viking Therapeutics Inc. stock maintain momentum in 2025Trade Ideas & Growth Focused Entry Reports - newser.com
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. - MSN
Will Viking Therapeutics Inc. stock attract more institutional investorsJuly 2025 Rallies & Technical Pattern Alert System - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedWeekly Market Summary & Weekly High Return Opportunities - newser.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Viking Therapeutics' (VKTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2.6%Here's Why - MarketBeat
Where is Viking Therapeutics (VKTX) Headed According to Analysts? - MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.3%Here's Why - MarketBeat
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts - Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Trading Up 8.6%Here's What Happened - MarketBeat
Why Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its Pipeline - Yahoo
What to expect from Viking Therapeutics Inc. in the next 30 daysJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
The Best Stocks to Invest $1,000 in Right Now - The Motley Fool
Is Viking Therapeutics’ (VKTX) Independent Path an Advantage in the Consolidating Metabolic Disease Market? - simplywall.st
Is Viking Therapeutics Inc. reversing from oversold territoryPortfolio Growth Summary & Real-Time Sentiment Analysis - newser.com
Short interest data insights for Viking Therapeutics Inc.July 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
How to use a screener to detect Viking Therapeutics Inc. breakoutsOil Prices & Capital Efficient Trading Techniques - newser.com
Viking Therapeutics Stock: A Speculative Buy (NASDAQ:VKTX) - Seeking Alpha
Why This Beaten-Down GLP-1 Stock Could Be a Steal - AOL.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 6.6%What's Next? - MarketBeat
Viking Therapeutics (VKTX): A Fresh Look at Valuation After Analyst Focus on Pipeline and Independence - simplywall.st
Using flow based indicators on Viking Therapeutics Inc.Market Growth Review & Capital Protection Trade Alerts - newser.com
Comparing Viking Therapeutics Inc. in custom built stock radars2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Viking Therapeutics Inc 주식 (VKTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ZANTE GREG | Chief Financial Officer |
Jul 03 '25 |
Sale |
27.76 |
4,266 |
118,428 |
168,660 |
| Mancini Marianna | Chief Operating Officer |
Jul 03 '25 |
Sale |
27.77 |
4,266 |
118,473 |
377,535 |
5.74%
자본화:
|
볼륨(24시간):